The FDA has cleared the Omnipod GO: a discreet, water-resistant insulin pod with up to 3 days of wear. Enjoy the freedom and convenience to manage your diabetes.

In case you missed them, below you’ll find our top stories from April 2023. This month’s best stories cover a wide variety of topics including medicare updates, upcoming...

From blood tests to self-injections and technology, needles are an inescapable part of diabetes care. If you have a fear of needles, there are several anxiety management...

On April 16, Medicare began covering people with type 2 diabetes for continuous glucose monitors (CGMs).

Researchers released clinical trial data on a new treatment for type 2 diabetes that may help the body’s insulin-producing cells regenerate. 78% of the clinical trial’s...

Mark Cuban’s Cost Plus Drug Company recently added SGLT-2 inhibitor Invokana to its list of available medications. The company, which uses an innovative business model...

A number of Libre users reported that their reader's lithium-ion battery swelled, overheated, sparked, and in rare cases, caught fire. In response, Abbott has issued a...

California Gov. Gavin Newsom announced a $50-million contract with Civica Rx to produce the state’s own insulin, adding to the recent new policies aiming to make this...

Diabetes is a growing health challenge in India, and with limited resources, innovative solutions are needed to improve management and outcomes.

Diabetes jewelry is more than just a fashion statement – it’s a lifesaving accessory.

A clinical trial is recruiting participants with type 2 diabetes and chronic kidney disease (CKD) to see how well a combination of glucose-lowering and kidney-protective...

Having diabetes puts you at risk for problems with your kidneys. Learn about the steps you can take, as recommended in the latest ADA Standards of Care, to maintain the...

In the US, it is estimated that 8.5 million people are unaware that they have T2D, which can lead to serious health problems. A new research project addressed this...

Learn more about the PsychoSocial Aspects of Diabetes (PSAD) Study Group and the professionals and people with diabetes making sure we prioritize more than just the...

In case you missed them, below you'll find our top five stories from February 2023. This month's best stories cover various topics including type 2 therapies, the latest...

At diaTribe’s Solvable Problems event in Berlin, we heard from esteemed physicians about their thoughts on the use of technology among people with diabetes.

At ATTD 2023, a panel of experts discussed the latest medications for weight loss and the treatment of obesity. The panel highlighted two FDA approved drugs, as well as...

New research from diaTribe and market research firm, dQ&A, is looking to explore how diabetes stigma might be impacting people’s willingness to use insulin pumps and...

Researchers at this week’s 2023 Advanced Technologies and Treatments for Diabetes (ATTD) conference in Berlin provided an update on icodec and efsitora, two new basal...

Leading clinicians at the ATTD conference discussed the need for greater CGM access for people with type 2 diabetes, as well as those with cystic fibrosis-related...